Race-Based Screening under the Public Health Ethics Microscope - The Case of Prostate Cancer

N Engl J Med. 2024 Aug 1;391(5):468-474. doi: 10.1056/NEJMms2402322.

Authors

Camilo Arenas-Gallo¹, Marsha Michie¹, Nora Jones¹, Peter J Pronovost¹, Randy A Vince Jr¹

Affiliation

¹ From the Departments of Bioethics and Medical Humanities (C.A.-G., M.M.) and Urology (C.A.-G., R.A.V.), University Hospitals Cleveland Medical Center, and the University Hospitals Health System, Case Western University School of Medicine (P.J.P.) - both in Cleveland; and the Center for Urban Bioethics, Lewis Katz School of Medicine, Temple University, Philadelphia (N.J.).

PMID: 39083779
DOI: 10.1056/NEJMms2402322

No abstract available

MeSH terms

Early Detection of Cancer* / ethics
Early Detection of Cancer* / statistics & numerical data
Humans
Incidence
Male
Mass Screening / ethics
Mass Screening / statistics & numerical data
Prostate-Specific Antigen / blood
Prostatic Neoplasms* / blood
Prostatic Neoplasms* / diagnosis
Prostatic Neoplasms* / epidemiology
Prostatic Neoplasms* / ethnology
Public Health / ethics
Public Health / statistics & numerical data
Racial Groups* / statistics & numerical data
United States / epidemiology
United States / ethnology

Substances

Prostate-Specific Antigen